QQ客服 官方微博 反馈留言

	Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial
	Zhang, Panpan; Gong, Yiyi; Liu, Zheng; Liu, Yanying; Lin, Wei; Li, Jieqiong; Wang, Mu; Liu, Xiaowei; Fei, Yunyun; Chen, Hua
	2019
卷号	22期号:8页码:1479-1488
关键词	B lymphocytes IgG4-RD iguratimod treatment
ISSN号	1756-1841
DOI	10.1111/1756-185X.13633
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6338222
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhang, Panpan,Gong, Yiyi,Liu, Zheng,et al. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial[J],2019,22(8):1479-1488.
APA	Zhang, Panpan.,Gong, Yiyi.,Liu, Zheng.,Liu, Yanying.,Lin, Wei.,...&Zhang, Wen.(2019).Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.,22(8),1479-1488.
MLA	Zhang, Panpan,et al."Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial".22.8(2019):1479-1488.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。